Annual report pursuant to Section 13 and 15(d)

15. Investment in Genomas, Inc. (Details Narrative)

v3.7.0.1
15. Investment in Genomas, Inc. (Details Narrative) - Genomas [Member]
7 Months Ended
Jul. 19, 2016
USD ($)
shares
Payment for acquisition | $ $ 250,000
Equity percentage owned 15.00%
Business combination, liabilities assumed | $ $ 1,500,000
Series A Preferred Stock of Genomas  
Business combination, stock received | shares 500,000
Series B Preferred Stock of Genomas  
Business combination, stock received | shares 345,000